Survival category | ||||
---|---|---|---|---|
0–30 days n = 2595 | > 30 days n = 11,250 | All n = 13,845 | Tests of association | |
Age group | ||||
< 60 | 253 (10) | 1990 (18) | 2243 (16) | χ2 = 268.78, df(3), p < 0.001 Somers’ d = 0.082 |
60–69 | 569 (22) | 3240 (29) | 3809 (28) | |
70–79 | 950 (37) | 3835 (34) | 4785 (35) | |
80+ | 823 (32) | 2185 (19) | 3008 (22) | |
Gender | ||||
Male | 1606 (62) | 6671 (59) | 8277 (60) | χ2 = 5.88, df(1), p = 0.015 Cramer’s V = 0.021 |
Female | 989 (38) | 4579 (41) | 5568 (40) | |
Marital status | ||||
Partner | 1224 (47) | 6193 (55) | 7417 (54) | χ2 = 52.66, df(1), p < 0.001 Cramer’s V = 0.062 |
Other | 1371 (53) | 5057 (45) | 6428 (46) | |
Smoker | ||||
Ever | 1803 (69) | 8641 (77) | 10,444 (75) | χ2 = 78.77, df(3), p < 0.001 Cramer’s V = 0.075 |
Never | 219 (8) | 915 (8) | 1134 (8) | |
Unknown | 573 (22) | 1694 (15) | 2267 (16) | |
Diagnosis episode admissiona | ||||
Elective | 360 (16) | 3990 (46) | 4350 (40) | χ2 = 635.33, df(1), p < 0.001 Cramer’s V = 0.242 |
Emergency | 1823 (84) | 4669 (54) | 6492 (60) | |
Diagnosis episode Charlson scorea | ||||
0 | 1362 (62) | 6481 (75) | 7843 (72) | χ2 = 134.08, df(2), p < 0.001 Cramer’s V = 0.114 |
1 | 403 (18) | 1166 (13) | 1569 (15) | |
> 1 | 418 (19) | 1012 (12) | 1430 (13) | |
Stageb | ||||
Stage 0/I/II | 183 (7) | 2148 (19) | 2331 (17) | χ2 = 365.11, df(3), p < 0.001 Somers’ d = 0.098 |
Stage III | 573 (22) | 3246 (29) | 3819 (28) | |
Stage IV | 1376 (53) | 4606 (41) | 5982 (43) | |
Un-staged | 463 (18) | 1250 (11) | 1713 (12) | |
Histologyc | ||||
Adenocarcinoma | 447 (17) | 3027 (27) | 3474 (25) | χ2 = 735.46, df(5), p < 0.001 Cramer’s V = 0.23 |
Carcinoma | 254 (10) | 1346 (12) | 1600 (12) | |
Large cell carcinoma | 121 (5) | 421 (4) | 542 (4) | |
Unspecified malignant | 951 (37) | 1715 (15) | 2666 (19) | |
Small cell carcinoma | 449 (17) | 1708 (15) | 2157 (16) | |
Squamous cell carcinoma | 373 (14) | 3033 (27) | 3406 (25) |